Tetrahedron Letters
A simple one-pot preparation of N-allenyl amides, ureas, carbamates
and sulfonamides using a DMSO/tBuOK protocol
⇑
Thomas W. Bousfield , Marc C. Kimber
Department of Chemistry, Loughborough University, Leicestershire LE11 3TU, UK
a r t i c l e i n f o
a b s t r a c t
Article history:
A one-pot transformation of amides, ureas, carbamates and sulfonamides into synthetically useful N-alle-
nyl analogues using a tBuOK/DMSO protocol is reported. The procedure is experimentally simple and
robust, and provides N-allenyl analogues, commonly used within the literature, in yields comparable
to the benchmark two-step approach.
Received 1 October 2014
Revised 17 October 2014
Accepted 20 November 2014
Available online 27 November 2014
Ó 2014 Elsevier Ltd. All rights reserved.
Keywords:
Amide
Allenamide
Propargyl bromide
One-pot
Lactam
N-Allenyl amides (allenamides), of the general structure 4, have
become an increasingly widespread and valuable synthon, with the
number of reports of their use increasing yearly (Scheme 1).1 While
synthetic approaches to these substrates have been well docu-
mented,1a it is the base-catalysed rearrangement of propargyl
amides that has presented itself as the stand-alone method of
choice for their synthesis.2,3 However, one of the drawbacks of this
method is the reliance on the formation and isolation of the prop-
argyl amide (3), which is in turn derived from an amide (1) and
propargyl bromide (2) under basic conditions.
To date, there have been two reports of the direct conversion of
amides into allenamides of the type 4 using this base-mediated
approach. In 2004, Pellón4 demonstrated that acridone (5) could
be transformed into the N-allenyl analogue (6) by heating
propargyl bromide (2) in an aqueous KOH/butanone solution in
the presence of a phase-transfer catalyst, while in 2005, Plumet5
demonstrated that lactams (7) could be transformed into their
N-allenyl analogues (8) using THF/KOH at room temperature.
In continuation of our interest in allenamides6 in Au-catalysed
transformations,7–12 we present a technically simple, yet robust
‘one-pot’ approach to synthesizing these valuable building blocks
using an adapted protocol of Heaney and Ley.13 We reported in
20106c that treatment of 2-oxazolidinone (9) and excess propargyl
bromide (2) with a mixture of DMSO/tBuOK was sufficient for full
conversion into the N-allenyl carbamate 10 in an isolated yield of
68% (Scheme 2).
Herein, we demonstrate the generality of this procedure for the
synthesis of a selection of N-allenyl amides, ureas, carbamates and
sulfonamides that have been used extensively in the literature, and
importantly, on an appreciable scale (20 mmol) (Table 1).14–17
Firstly, the synthesis of 10 could be confidently scaled up to
20 mmol with no discernable decrease in the isolated yield (entry
1). Using this procedure,14 the cyclic lactams 11a–c were converted
in moderate to good yields under these DMSO/tBuOK conditions
(entries 2–4), however, unlike the work of Plumet, the larger ring
size did not result in diminished isolated yields of the allenamide,
as highlighted by 12c (entry 4). Imidazolin-2-ones 13a and b were
smoothly converted into their respective N-allenyl ureas, with 14b
being the first reported example of a bis-N-allenyl urea, to our
knowledge (entries
5 and 6). All three chiral oxazolidinones
15a–c could be cleanly converted into N-allenyl carbamates 16a–c
(entries 7–9), and pleasingly N-methyl p-toluenesulfonamide (17)
could be transformed into N-allenyl sulfonamide 18 in a good yield
of 68% (entry 10). The previous route to this commonly used
N-allenyl sulfonamide 18 relied on sulfonamide formation on
N-methylpropargyl amine, and as such, this new approach
represents a significantly cheaper and technically easier method
for its synthesis.7e Acridone (5) could be transformed into its
N-allenyl analogue 19, but its purification proved difficult and this
is reflected in a poor overall isolated yield of only 12% (entry 11).
Finally, imidazole (20) gave the desired N-allenyl analogue 2118
in a good yield of 54% (entry 12).
⇑
Corresponding author. Tel.: +44 (0) 01509 22 2570.
Tel.: +44 (0) 01509 22 2570.
0040-4039/Ó 2014 Elsevier Ltd. All rights reserved.